Psychotropic drugs are medications that affect mood, perception, cognition, and behavior by acting on the central nervous system. They include antidepressants, antipsychotics, mood stabilizers, anxiolytics, and stimulants — all crucial in managing psychiatric and neurological conditions.

The Psychotropic Drugs session investigates the pharmacology, therapeutic mechanisms, and long-term effects of these medications. Researchers examine receptor binding, neurotransmitter modulation, and individual variability in treatment response.

At the Psychotropic Drugs Conference, psychiatrists, neurologists, and neuroscientists discuss novel drug formulations, side-effect reduction, and innovations in neurochemical targeting. Emphasis is placed on translational approaches combining clinical research, neuroimaging, and computational pharmacology.

This session is designed for clinicians, pharmacologists, and researchers exploring brain–behavior interactions. Participants will learn about treatment personalization, polypharmacy management, and the ethical implications of psychopharmacology.

Recent developments in Neuropsychopharmacology reveal molecular pathways underlying mood stabilization and cognitive enhancement, driving the creation of safer and more targeted therapies.